s.adebayo
TL2 · Ilorin
Contributes reviews on supplier material. Based in Ilorin.
Joined 14 May 2025 · last posted 9d
94 posts, newest first. Showing up to 150.
-
Insurance and replacement policies, compared Replied, post #101 · Sourcing › Logistics · 19 Jul 2026 · 1 like Everything in post #99 holds. The case it does not cover is the one I have. Small methodological point on insurance and replacement policies: repeating a measurement is…
-
What a certificate commits its issuer to Replied, post #58 · Analytics › COA interpretation · 19 Jul 2026 · 1 like The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
What a reversed-phase purity number actually is Replied, post #46 · Analytics › HPLC & UHPLC · 12 Jul 2026 · 13 likes Building on post #45 rather than restating it. The number people quote for reversed-phase purity number is a central estimate presented without its interval, and the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #99 · Compounds › Semaglutide · 10 Jul 2026 · 7 likes The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares only the active molecule. Absorption enhancers, fasting requirements…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #39 · Pharmacology › Receptor biology · 9 Jul 2026 · 15 likes The arithmetic in post #38 is right; the assumption feeding it is the part to check. Nothing in receptor biology tells you what is in the vial, which is worth…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #73 · Compounds › Oral incretins · 3 Jul 2026 · 0 likes That is a cleaner way of putting what I was circling around.
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #12 · Clinical › Bloodwork · 3 Jul 2026 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Publication patterns in the BPC-157 literature, examined Replied, post #25 · Compounds › Repair & healing peptides · 1 Jul 2026 · 2 likes Thank you for taking the time. That was more work than a reply usually is.
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #52 · Practice › Dosing & titration · 20 Jun 2026 · 0 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Batch numbers that do not match the vial label — what changed since Replied, post #41 · Sourcing › Red flags · 19 Jun 2026 · 1 like Marking my uncertainty on Batch numbers explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
-
Does a peptide degrade silently, with no visual change? Replied, post #49 · Practice › Storage & stability · 16 Jun 2026 · 22 likes Coming back to post #47, because the follow-up matters more than the original answer. Clarity is a weak test. A solution can lose a significant fraction of its active…
-
Racemisation and why it is invisible to a mass measurement Replied, post #25 · Analytics › Impurities & related substances · 9 Jun 2026 · 11 likes Adding the boring version of racemisation, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #25 · Evidence › Meta-analyses · 9 Jun 2026 · 0 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #26 · Start Here › How to Ask · 8 Jun 2026 · 31 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #59 · Sourcing › Red flags · 7 Jun 2026 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #55 · Sourcing › Red flags · 5 Jun 2026 · 27 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at scale.
-
Private prescribing in the UK: what is actually involved Replied, post #26 · Regional › UK & Ireland · 30 May 2026 · 4 likes Post #22 put the caveat in the right place and I want to underline it. Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently…
-
The best-written scientific paper you have read Replied, post #55 · Lounge › Off topic · 20 May 2026 · 13 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic. It took…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #19 · Sourcing › Independent verification · 17 May 2026 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. That is one dataset and I would not build…
-
Tracking intake honestly when appetite is absent Replied, post #27 · Nutrition & Training › Protein & intake · 16 May 2026 · 31 likes Where the tracking intake discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Alcohol: what is documented and what is folklore Replied, post #12 · Practice › Interactions · 14 May 2026 · 1 like Narrowing post #9, because the general version has more than one answer. The useful distinction on alcohol is between what was measured and what was inferred from it.…
-
Blind submission and why it changes minds — the long version Replied, post #44 · Sourcing › Independent verification · 27 Apr 2026 · 0 likes What I would want before treating Blind submission as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #53 · Sourcing › Vendor reports · 19 Apr 2026 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #19 · Practice › Reconstitution · 19 Apr 2026 · 11 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #13 · Practice › Reconstitution · 16 Apr 2026 · 2 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #71 · Research Methods › Statistics · 6 Apr 2026 · 10 likes Coming back to post #70, because the follow-up matters more than the original answer. Where an analysis was changed after seeing the data, the honest thing is to report…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #93 · Clinical › Special populations · 31 Mar 2026 · 0 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #70 · Compounds › Cagrilintide & amylin analogues · 16 Mar 2026 · 5 likes Adding a small correction to the nausea profile of amylin analogues summary above rather than a disagreement with it. The substance holds; one of the figures is out by…
-
Coming back to: Training through a dose escalation week Replied, post #53 · Nutrition & Training › Resistance training · 16 Mar 2026 · 7 likes No disagreement from me. Posting only so the question does not look ignored.
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #40 · Compounds › Semaglutide · 3 Mar 2026 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Splitting an overlong document into two Replied, post #5 · Documentation › Wiki requests · 26 Feb 2026 · 10 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. I am describing what is, rather than…
-
Measurement error in a self-reported exposure Replied, post #56 · Evidence › Study critique · 24 Feb 2026 · 17 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #134 · Sourcing › Independent verification · 23 Feb 2026 · 20 likes This follows post #131 rather than contradicting it. Two claims get bundled together under interpreting a result and they need separating. The descriptive one — this is…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #19 · Evidence › Journal club · 20 Feb 2026 · 28 likes Everything in post #15 holds. The case it does not cover is the one I have. Counterpoint on SURMOUNT-1, offered without confidence: the same observation is consistent…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Started this topic · Analytics › Impurities & related substances · 18 Feb 2026 · 33 likes Posting this under the heading it deserves: Second pass at: Where impurities in solid-phase peptide synthesis come from Everything below is what sits behind that.…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #30 · Practice › Storage & stability · 31 Jan 2026 · 6 likes Useful. I have added it to my own notes with the date on it.
-
Citation sweep results: how many references did not say what was claimed Replied, post #37 · Meta › Wiki maintenance · 28 Jan 2026 · 10 likes Post #33 put the caveat in the right place and I want to underline it. Citation sweep results was covered in the wiki last year and the page has a review date on it,…
-
What consumer-accessible tests can and cannot determine Started this topic · Analytics › Home & field testing · 25 Jan 2026 · 16 likes What consumer-accessible tests can and cannot determine — that is the question, and I have not found it answered plainly anywhere I have looked. Something about…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #43 · Clinical › Special populations · 23 Jan 2026 · 20 likes Worth separating two things that post #39 runs together. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #34 · Evidence › Trials · 11 Jan 2026 · 25 likes Fair, and the limits you put on it are the part I will remember.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #33 · Practice › Side effects · 8 Jan 2026 · 7 likes Post #30 is the version of this I will quote in future. One addition. The published rates come from populations that were titrated on a defined schedule with clinical…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #88 · Practice › Reconstitution · 29 Nov 2025 · 16 likes Where I have landed on Over-dilution, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #74 · Practice › Dosing & titration · 11 Nov 2025 · 24 likes Post #72 describes the usual case. This is about the unusual one. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #27 · Compounds › Other compounds · 11 Nov 2025 · 7 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #11 · Practice › Side effects · 26 Oct 2025 · 0 likes Posting my Constipation management numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Follow-up: What a seizure notice actually says Replied, post #7 · marked as the solution · Sourcing › Logistics · 24 Oct 2025 · 7 likes On seizure notice the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Payment mechanics and the recovery options that do not exist Replied, post #28 · Sourcing › Payments · 19 Oct 2025 · 7 likes Something worth flagging about payment mechanics: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not…
-
Sleep tracking data and its considerable limitations Replied, post #15 · Wellbeing › Sleep · 16 Oct 2025 · 5 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
Compounds this community declines to help with, and why Replied, post #44 · Compounds › Other compounds · 1 Oct 2025 · 9 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #88 · Practice › Side effects · 24 Sep 2025 · 0 likes This follows post #85 rather than contradicting it. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site…
-
Temperature loggers worth the money Replied, post #32 · Devices › Cold chain · 20 Sep 2025 · 0 likes Thank you — that answers what I came here to find out.
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #47 · Compounds › Other compounds · 17 Sep 2025 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
Titles that describe the question, not the situation — what changed since Replied, post #10 · Start Here › How to Ask · 12 Sep 2025 · 0 likes I had written a reply contradicting post #6 and deleted it. Here is what survived. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Column chemistry choices for a 40-residue peptide Replied, post #22 · Analytics › HPLC & UHPLC · 27 Aug 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #44 · Sourcing › Vendor reports · 22 Aug 2025 · 0 likes Where I part company with post #40, and it is a narrow parting. The documentation on vendor documentation pages is better than this thread and I say that as someone who…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #98 · Compounds › Retatrutide · 20 Aug 2025 · 0 likes This follows post #97 rather than contradicting it. Whether triple agonism is additive or synergistic is an open question and the published work does not answer it. A…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #4 · Practice › Storage & stability · 16 Aug 2025 · 21 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #89 · Outcomes › Progress reports · 2 Aug 2025 · 3 likes Narrowing post #88, because the general version has more than one answer. The practical version of 18-month record is three sentences long. The rigorous version is…
-
A friction point in the promotion workflow Replied, post #3 · Meta › Site feedback · 31 Jul 2025 · 2 likes Everything in the opening post holds. The case it does not cover is the one I have. Seconding that. I would put solved-only in front of the sort control rather than…
-
Travel coolers and how long they really hold Replied, post #4 · Devices › Cold chain · 30 Jul 2025 · 5 likes Where the travel coolers reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Specification in the result column: why that is a meaningful error Replied, post #24 · Analytics › COA interpretation · 28 Jul 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Research-use-only labelling: what it means and what it does not Replied, post #13 · Sourcing › Regulatory · 19 Jul 2025 · 29 likes Everything in post #9 holds. The case it does not cover is the one I have. The version of research-use-only labelling that circulates here is a simplification of a…
-
[2026 update] Cold solution and stinging: the simplest fix Replied, post #3 · Practice › Administration · 14 Jul 2025 · 0 likes No notes. Posting so the count is not one.
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #10 · Practice › Reconstitution · 8 Jul 2025 · 5 likes Post #6 put the caveat in the right place and I want to underline it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #2 · Practice › Storage & stability · 4 Jul 2025 · 0 likes Adding a data point of agreement rather than a data point.
-
Second pass at: Coverage in the US: a map of the usual obstacles Started this topic · Regional › North America · 2 Jul 2025 · 8 likes On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. Two things I would like separated…
-
Counter-ion content and its effect on measured mass Replied, post #80 · Analytics › Mass spectrometry · 2 Jul 2025 · 6 likes A note on how counter-ion content gets discussed rather than on counter-ion content itself: the confident posts get the replies and the careful ones get ignored, and…
-
Interim analyses and stopping rules — does this still hold? Replied, post #7 · Evidence › Trials · 25 Jun 2025 · 4 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #5 · Pharmacology › Pharmacokinetics · 17 May 2025 · 0 likes Picking up post #2: that is the part I would want checked first. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody…
-
Reading order for a first week here, and what to skip until later Replied, post #101 · Start Here › Welcome · 25 Apr 2025 · 24 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #24 · Practice › Storage & stability · 18 Apr 2025 · 1 like Checked the published stability data actually covers claim against the primary source this morning. It survives, with a narrower scope than the version quoted here.…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #85 · Devices › Cold chain · 14 Apr 2025 · 18 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #90 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from one. Our vendor pages deliberately mix services for that…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #3 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Consistent declarations and why they matter more than clever ones Replied, post #128 · Sourcing › Logistics · 5 Mar 2025 · 9 likes Everything in post #126 holds. The case it does not cover is the one I have. Anyone deciding whether a delay is a problem should ask what would change if they waited…
-
A promotion I argued against, and why I lost Replied, post #112 · Documentation › Doc review · 26 Feb 2025 · 4 likes What I want from this promotion thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Scheduled maintenance and what will be unavailable Replied, post #50 · Meta › Announcements · 21 Feb 2025 · 15 likes Taking post #47 at face value and following it one step further. Thank you for announcing it in advance rather than after. The number of places that do the reverse is…
-
Canadian access and provincial variation Replied, post #35 · Regional › North America · 30 Jan 2025 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Oxidation pathways for methionine and tryptophan Replied, post #39 · Analytics › Impurities & related substances · 29 Dec 2024 · 14 likes Worth separating two things that post #36 runs together. Relative response factors mean impurities are not detected in proportion to how much of them is present. A one…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #13 · Compounds › Semaglutide · 17 Dec 2024 · 8 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
The topic list is dense — is that deliberate? Replied, post #60 · Meta › Site feedback · 1 Dec 2024 · 7 likes The counter-argument is that a review date on a topic implies a maintenance promise nobody has made. A document carries one because somebody signed up to it.
-
Coming back to: When to suspect the method rather than the sample Replied, post #12 · Analytics › Method validation · 30 Nov 2024 · 3 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #158 · Compounds › Repair & healing peptides · 26 Nov 2024 · 4 likes Where I part company with post #156, and it is a narrow parting. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal —…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #17 · Clinical › Special populations · 24 Nov 2024 · 1 like Renal and hepatic impairment studies are usually small dedicated pharmacokinetic studies rather than outcome trials, and they answer exposure questions only. That is…
-
Time to steady state after a dose increase Replied, post #29 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 21 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
-
Reading a supplementary appendix and finding the interesting part Replied, post #15 · Evidence › Trials · 31 Oct 2024 · 32 likes Two claims get bundled together under reading a supplementary appendix and they need separating. The descriptive one — this is what was observed — is usually well…
-
Requesting a page: what makes a good request — what changed since Replied, post #61 · Documentation › Wiki requests · 11 Oct 2024 · 0 likes This follows post #58 rather than contradicting it. Requests for a page summarising a supplier are declined, because that is what the vendor documentation set is for…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #75 · Clinical › Prescriber conversations · 11 Oct 2024 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Take it as a starting point and not as a specification.
-
Signs of dehydration worth acting on Replied, post #26 · Safety › Adverse events · 7 Oct 2024 · 5 likes Building on post #24 rather than restating it. Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #23 · Compounds › Other compounds · 29 Sep 2024 · 0 likes Picking up post #21: that is the part I would want checked first. Taking Melanocortin agonists seriously for a moment rather than deflecting: the honest position is…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #27 · Analytics › COA interpretation · 10 Aug 2024 · 13 likes Purity assay versus content assay has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #13 · Devices › Syringes & needles · 25 Jul 2024 · 10 likes Post #12 is the version of this I will quote in future. One addition. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to…
-
How this community labels and discusses unrefereed work Replied, post #84 · Evidence › Preprints · 14 Jul 2024 · 28 likes Post #83 put the caveat in the right place and I want to underline it. The documentation on community labels is better than this thread and I say that as someone who…
-
Assessing a warm arrival: the decision process — one year on Replied, post #68 · Sourcing › Logistics · 31 May 2024 · 15 likes I think the Assessing a warm arrival question is answerable and has not been answered, which is a more optimistic position than most of this thread.